SCHEMBL20952920

SCHEMBL20952920

CC(CS)c1n[nH]c2c(Cl)cccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.54
FLT3 P36888 1/20 0.54
PLK3 Q9H4B4 1/20 0.54
ADRA2A P08913 1/20 0.36
NOS1 P29475 2/20 0.33
DAO P14920 1/20 0.33
AR P10275 1/20 0.33
HTR2A P28223 1/20 0.32
GAA P10253 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2A6 P11509 1/20 0.31
SLC6A4 P31645 1/20 0.31
RARG P13631 1/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
MAP4K4 O95819 1/20 0.30
CSF1R P07333 1/20 0.30
FGFR1 P11362 1/20 0.30
PDGFRA P16234 1/20 0.30
LTK P29376 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16675891 0.82 CHEK1 (0.58) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL3004142 0.71 CHEK1 (1.00) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL13122682 0.70 CHEK1 (0.63) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL13122699 0.69 CHEK1 (0.58) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL30040295 0.68 CHEK1 (0.66) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL15866141 0.68 CHEK1 (0.66) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL20024820 0.67 IDO1 (0.38) CYP1A2CYP2A6SLC6A4KDM4EPOLB
SCHEMBL20674191 0.66 CHEK1 (0.63) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL29361454 0.66 CHEK1 (0.63) CHEK1FLT3PLK3ADRA2ANOS1
SCHEMBL17515574 0.66 CHEK1 (0.58) CHEK1FLT3PLK3ADRA2ANOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10273243-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-04-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10273243-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, CYP4F3 CHEK1 2734/4885FLT3 577/4885PLK3 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.